| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.41B | 8.16B | 6.79B | 5.94B | 4.84B | 3.00B |
| Gross Profit | 4.51B | 4.39B | 2.94B | 2.91B | 1.79B | 1.31B |
| EBITDA | 1.53B | 1.37B | 1.34B | 1.09B | 1.13B | 745.98M |
| Net Income | 707.00M | 637.40M | 578.88M | 524.19M | 647.62M | 391.24M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 9.85B | 8.45B | 7.12B | 5.53B | 3.91B |
| Cash, Cash Equivalents and Short-Term Investments | 680.20M | 671.60M | 116.66M | 206.29M | 113.47M | 182.28M |
| Total Debt | 0.00 | 2.76B | 3.12B | 2.35B | 1.50B | 1.07B |
| Total Liabilities | -5.31B | 4.54B | 4.87B | 4.05B | 2.96B | 1.97B |
| Stockholders Equity | 5.31B | 5.27B | 3.54B | 3.03B | 2.54B | 1.91B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -541.80M | -352.86M | 132.83M | -255.80M | 88.65M |
| Operating Cash Flow | 0.00 | -68.80M | 578.37M | 711.62M | 516.40M | 454.19M |
| Investing Cash Flow | 0.00 | -424.50M | -1.02B | -1.36B | -725.06M | -347.59M |
| Financing Cash Flow | 0.00 | 534.40M | 483.93M | 641.19M | 184.07M | -88.45M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹25.83B | 31.74 | ― | 0.26% | 11.21% | 22.23% | |
66 Neutral | ₹11.65B | 28.72 | ― | ― | 7.32% | ― | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | ₹63.61B | 198.43 | ― | 0.16% | 11.84% | -73.79% | |
55 Neutral | ₹19.77B | 44.44 | ― | 0.50% | 7.89% | 32.07% | |
47 Neutral | ₹22.13B | -29.92 | ― | 0.15% | -7.26% | -408.66% | |
46 Neutral | ₹7.16B | -33.41 | ― | ― | -30.79% | 59.95% |
Carysil Limited has announced the opening of a special window for the re-lodgement of transfer requests for physical shares, in compliance with SEBI guidelines. This move is significant for stakeholders as it facilitates the transfer process of physical shares, potentially impacting the company’s operations and market positioning by aligning with regulatory standards.
Carysil Limited has released an investor presentation for the second quarter and first half of fiscal year 2026, highlighting its strategic initiatives such as brand development, talent acquisition, diversification, expansion, innovation, and globalization. These efforts are aimed at accelerating the company’s momentum and enhancing its competitive positioning in the global market.
Carysil Limited has released a Monitoring Agency Report for the quarter ended September 30, 2025, detailing the utilization of funds raised through a Qualified Institutions Placement. The report, issued by ICRA Limited, is part of compliance with SEBI regulations and aims to ensure transparency in the use of capital. This announcement underscores Carysil’s commitment to regulatory compliance and could enhance stakeholder confidence in the company’s financial management.